Memory, Reconciliation and Chosen Traumas: the Political Psychology of the Chinese State, Media and Public on Sino-Japanese Relations

Master'sMASTER OF SOCIAL SCIENCE

A Simple Approach to Sample Size Calculation for Count Data in Matched Cohort Studies

In matched cohort studies exposed and unexposed individuals are matched on certain characteristics to form clusters to reduce potential confounding effects. Data in these studies are clustered and thus dependent due to matching. When the outcome is a Poisson count, specialized methods have been proposed for sample size estimation. However, in practice the variance of the counts often exceeds the mean (i.e. counts are overdispersed), so that Poisson methods don't apply. We propose a simple approach for calculating statistical power and sample size for clustered Poisson data when the proportion of exposed subjects in a cluster is constant across clusters. We extend the approach to clustered count data with overdispersion, which is common in practice. We evaluate these approaches with simulation studies and apply them to a matched cohort study examining the association of parental depression with health care utilization. Simulation results show that the methods for estimating power and sample size performed reasonably well under the scenarios examined and were robust in the presence of mixed exposure proportions up to 30%

TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines

A major goal of immunotherapy for cancer is the activation of T cell responses against tumor-associated antigens (TAAs). One important strategy for improving antitumor immunity is vaccination with peptide variants of TAAs. Understanding the mechanisms underlying the expansion of T cells that respond to the native tumor antigen is an important step in developing effective peptide-variant vaccines. Using an immunogenic mouse colon cancer model, we compare the binding properties and the TCR genes expressed by T cells elicited by peptide variants that elicit variable antitumor immunity directly ex vivo. The steady-state affinity of the natural tumor antigen for the T cells responding to effective peptide vaccines was higher relative to ineffective peptides, consistent with their improved function. Ex vivo analysis showed that T cells responding to the effective peptides expressed a CDR3β motif, which was also shared by T cells responding to the natural antigen and not those responding to the less effective peptide vaccines. Importantly, these data demonstrate that peptide vaccines can expand T cells that naturally respond to tumor antigens, resulting in more effective antitumor immunity. Future immunotherapies may require similar stringent analysis of the responding T cells to select optimal peptides as vaccine candidates. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00262-012-1217-5) contains supplementary material, which is available to authorized users

CTLA4 mRNA is downregulated by miR-155 in regulatory T cells, and reduced blood CTLA4 levels are associated with poor prognosis in metastatic melanoma patients

Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) is an immune checkpoint expressed in regulatory T (Treg) cells and activated T lymphocytes. Despite its potential as a treatment strategy for melanoma, CTLA-4 inhibition has limited efficacy. Using data from The Cancer Genome Atlas (TCGA) melanoma database and another dataset, we found that decreased CTLA4 mRNA was associated with a poorer prognosis in metastatic melanoma. To investigate further, we measured blood CTLA4 mRNA in 273 whole-blood samples from an Australian cohort and found that it was lower in metastatic melanoma than in healthy controls and associated with worse patient survival. We confirmed these findings using Cox proportional hazards model analysis and another cohort from the US. Fractionated blood analysis revealed that Treg cells were responsible for the downregulated CTLA4 in metastatic melanoma patients, which was confirmed by further analysis of published data showing downregulated CTLA-4 surface protein expression in Treg cells of metastatic melanoma compared to healthy donors. Mechanistically, we found that secretomes from human metastatic melanoma cells downregulate CTLA4 mRNA at the post-transcriptional level through miR-155 while upregulating FOXP3 expression in human Treg cells. Functionally, we demonstrated that CTLA4 expression inhibits the proliferation and suppressive function of human Treg cells. Finally, miR-155 was found to be upregulated in Treg cells from metastatic melanoma patients compared to healthy donors. Our study provides new insights into the underlying mechanisms of reduced CTLA4 expression observed in melanoma patients, demonstrating that post-transcriptional silencing of CTLA4 by miRNA-155 in Treg cells may play a critical role. Since CTLA-4 expression is downregulated in non-responder melanoma patients to anti-PD-1 immunotherapy, targeting miRNA-155 or other factors involved in regulating CTLA4 expression in Treg cells without affecting T cells could be a potential strategy to improve the efficacy of immunotherapy in melanoma. Further research is needed to understand the molecular mechanisms regulating CTLA4 expression in Treg cells and identify potential therapeutic targets for enhancing immune-based therapies

Effect of Recycle Solvent Hydrotreatment on Oil Yield of Direct Coal Liquefaction

Effects of the recycle solvent hydrotreatment on oil yield of direct coal liquefaction were carried out in the 0.18 t/day direct coal liquefaction bench support unit of National Engineering Laboratory for Direct Coal Liquefaction (China). Results showed that the hydrogen-donating ability of the hydrogenated recycle solvent improved and the hydrogen consumption of solvent hydrotreatment was increased by decreasing liquid hourly space velocity (LHSV) from 1.5 to 1.0 h−1 and increasing reaction pressure from 13.7 to 19.0 MPa. The hydrogen-donating ability of the hydrogenated recycle solvent was enhanced, thus promoting the oil yield and coal conversion of the liquefaction reaction. The coal conversion and distillates yield of coal liquefaction were increased from 88.74% to 88.82% and from 47.41% to 49.10%, respectively, with the increase in the solvent hydrotreatment pressure from 13.7 to 19.0 MPa. The coal conversion and distillates of coal liquefaction were increased from 88.82% to 89.27% and from 49.10% to 54.49%, respectively, when the LHSV decreased from 1.5 to 1.0 h−1 under the solvent hydrotreatment pressure of 19.0 MPa